Alvotech And Teva Are Latest With US Eylea Settlement

Aflibercept Deal Allows Entry From Q4 2026 – If CRL Can Be Overcome

 
• By Dave Wallace
  
Xbrane is eyeing FDA approval in October (Shutterstock)

More from Deals

More from Business